Mirae Asset Global Investments Co., Ltd. Deciphera Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 32,370 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,370
Previous 41,527
22.05%
Holding current value
$0
Previous $669,000
23.92%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding DCPH
# of Institutions
166Shares Held
58.6MCall Options Held
5.3KPut Options Held
27.6K-
Black Rock Inc. New York, NY5.99MShares$00.0% of portfolio
-
Armistice Capital, LLC New York, NY5.9MShares$01.26% of portfolio
-
Redmile Group, LLC San Francisco, CA5.3MShares$03.28% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.13MShares$01.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...